Burden of diabetic peripheral neuropathy in a rural demography of India is revealed by biothesiometry: a reliable screening tool

Dinesh Annadurai; Ganesh Kumar P.; Srisakthi J.

doi:10.18203/2349-2902.isj20250140

Authors

Dinesh Annadurai Department of General Medical, Government Villupuram Medical College and Hospital, Villupuram, Tamil Nadu, India
Ganesh Kumar P. Department of General Medical, Government Villupuram Medical College and Hospital, Villupuram, Tamil Nadu, India
Srisakthi J. Department of General Medical, Government Villupuram Medical College and Hospital, Villupuram, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2349-2902.isj20250140

Keywords:

Diabetic peripheral neuropathy, Diabetic foot ulcer, Biothesiometry

Abstract

Background: Diabetes mellitus (DM) is the most prevalent non-communicable disease in the world estimated to be 4.4% in 2030 globally. Among its complications, diabetic peripheral neuropathy (DPN) is the common disorder manifested as ‘glove and stocking sensation’ in the lower extremities. Aim to study the prevalence and to grade DPN in patients attending OPD.

Methods: Patients coming to the general surgery and plastic surgery outpatient department were selected. A total of 331 patients will be asked history by a simple questionnaire and symptoms are graded by modified neuropathy symptom score (MNSS) and clinical examination are done and graded by diabetic neuropathy examination (DNE) and vibration perception threshold (VPT) is measured by biothesiometry.

Results: Among the DPN patients, 57.40% are asymptomatic and 12.08% are having severe symptoms by MNDS score and about 27.49% having increased risk for pronation for foot ulcer by DNE score and about 43.2% having risk for foot ulcer by biothesiometry average from the most common site for loss of sensation involving over 1^st, 3^rd, 5^th metatarsal head to the least involved site as midfoot.

Conclusions: This study reveals the impact of DPN in a rural area, so by implementing this type of screening method reduces the development of foot ulcers by about 60% in asymptomatic patients and leg amputations by 85% in patients with severe stage of DPN with proper foot care.

Metrics

Metrics Loading ...

References

Trikkalinou A, Papazafiropoulou AK, Melidonis A. Type 2 diabetes and quality of life. World J Diabetes 2017;8:120-9. DOI: https://doi.org/10.4239/wjd.v8.i4.120

Saeedi P, Petersohn I, Salpea P, Belma M, Suvi K, Nigel U, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157:107843.

Barrett AM, Lucero MA, Le T, Rebecca LR, Robert HD, Amy SC, et al. Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Med. 2007;8(2):S50-62. DOI: https://doi.org/10.1111/j.1526-4637.2006.00179.x

Tesfaye S, Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev. 2012;28(1):8-14. DOI: https://doi.org/10.1002/dmrr.2239

Ang L, Jaiswal M, Martin C, Rodica PB. Glucose control and diabetic neuropathy: lessons from recent large clinical trials. Curr Diab Rep 2014;14(9):528. DOI: https://doi.org/10.1007/s11892-014-0528-7

Pop-Busui R, Lu J, Brooks MM, Stewart A, Andrew DA, Jorge E, et al. Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort. Diabetes Care. 2013;36(10):3208-15. DOI: https://doi.org/10.2337/dc13-0012

Martin CL, Albers JW, Pop-Busui R, DCCT/EDIC Research Group. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care 2014;37(1):31-8. DOI: https://doi.org/10.2337/dc13-2114

Gylfadottir SS, Itani M, Krøigård T. Diagnosis and prevalence of diabetic polyneuropathy: a cross-sectional study of Danish patients with type 2 diabetes. Eur J Neurol 2020;27:2575-85. DOI: https://doi.org/10.1111/ene.14469

Kisozi T, Mutebi E, Kisekka M, Samden L, Martha S, Mark K, et al. Prevalence, severity and factors associated with peripheral neuropathy among newly diagnosed diabetic patients attending Mulago hospital: a cross-sectional study. Afr Health Sci. 2017;17(2):463-73. DOI: https://doi.org/10.4314/ahs.v17i2.21

Abdissa D. Prevalence and associated factors of painful diabetic peripheral neuropathy among diabetic patients on follow up at Jimma University Medical Center. J Diabetes Metab Disord. 2020;19:1407-13. DOI: https://doi.org/10.1007/s40200-020-00661-7

Albers JW, Pop-Busui R. Diabetic neuropathy: mechanisms, emerging treatments, and subtypes. Curr Neurol Neurosci Rep. 2014;14:473. DOI: https://doi.org/10.1007/s11910-014-0473-5

Rastogi A, Jude EB. Novel treatment modalities for painful diabetic neuropathy. Diabetes Metab Syndr 2021;15:287-93. DOI: https://doi.org/10.1016/j.dsx.2021.01.004

Yang S, Kwak SG, Choi GS, Min CC. Short-term Effect of Repetitive Transcranial Magnetic Stimulation on Diabetic Peripheral Neuropathic Pain. Pain Physician. 2022;25(2):E203-9.

Feldman EL, Callaghan BC, Pop-Busui R, Douglas WZ, Douglas EW, David LB, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019;5:41. DOI: https://doi.org/10.1038/s41572-019-0092-1

Muramatsu K. Diabetes Mellitus-Related Dysfunction of the Motor System. Int J Mol Sci 2020;21:7485. DOI: https://doi.org/10.3390/ijms21207485

Dubin AE, Patapoutian A. Nociceptors: the sensors of the pain pathway. J Clin Invest. 2010;120:3760-72. DOI: https://doi.org/10.1172/JCI42843

Barbano R, Hart-Gouleau S, Pennella-Vaughan J, Dworkin RH. Pharmacotherapy of painful diabetic neuropathy. Curr Pain Headache Rep. 2003;7(3):169-77. DOI: https://doi.org/10.1007/s11916-003-0070-9

Assal JP, Lindblom U. Consensus Conference on Diabetic Peripheral Neuropathy, 1988, San Antonio, Texas. Muscle Nerve. 1989;12(3):246.

Meijer JW, van Sonderen E, Blaauwwiekel EE, Smit AJ, Groothoff JW, Eisma WH, et al. Diabetic neuropathy examination: a hierarchical scoring system to diagnose distal polyneuropathy in diabetes. Diabetes Care. 2000;23(6):750-3. DOI: https://doi.org/10.2337/diacare.23.6.750

Kamela SR, Mona H, Omara HASA, Amal K, Lamia HA, Ahmed HAE. Clinical diagnosis of distal diabetic polyneuropathy using neurological examination scores: correlation with nerve conduction studies. Egypt Rheumatol Rehabilit. 2015;42:128-36. DOI: https://doi.org/10.4103/1110-161X.163945

Asad A, Hameed MA, Khan UA, Ahmed N, Butt MU. Reliability of the neurological scores for assessment of sensorimotor neuropathy in type 2 diabetics. J Pak Med Assoc. 2010;60(3):166-70.

Veves A, Murray HJ, Young MJ, Boulton AJ. The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study. Diabetologia. 1992;35(7):660-3. DOI: https://doi.org/10.1007/BF00400259

Franklin GM, Kahn LB, Baxter J, Marshall JA, Hamman RF. Sensory neuropathy in non-insulin-dependent diabetes mellitus. The San Luis Valley Diabetes Study. Am J Epidemiol. 1990;131(4):633-43. DOI: https://doi.org/10.1093/oxfordjournals.aje.a115547

Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36(2):150-4. DOI: https://doi.org/10.1007/BF00400697

Boulton AJ, Kubrusly DB, Bowker JH, Gadia MT, Quintero L, Becker DM, et al. Impaired vibratory perception and diabetic foot ulceration. Diabet Med. 1986;3(4):335-7. DOI: https://doi.org/10.1111/j.1464-5491.1986.tb00775.x

Young MJ, Breddy JL, Veves A, Boulton AJ. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care. 1994;17(6):557-60. DOI: https://doi.org/10.2337/diacare.17.6.557

Barth R, Campbell LV, Allen S, Jupp JJ, Chisholm DJ. Intensive education improves knowledge, compliance, and foot problems in type 2 diabetes. Diabet Med. 1991;8(2):111-7. DOI: https://doi.org/10.1111/j.1464-5491.1991.tb01555.x

Connor H. The economic impact of diabetic foot disease. In The Foot in Diabetes. 12. Delbridge L, Perry P, Marr S, Arnold N, Yue DK, Turtle JR, et al. Limited joint mobility in the diabetic foot: relationship to neuropathic ulceration. Diabetic Med 5:333-337, 1988 Connor H, Boulton AJM, Ward JD, Eds. Chichester, England, John Wiley and Sons, 1987: 145-149. DOI: https://doi.org/10.1111/j.1464-5491.1988.tb01000.x

Bild DE, Selby JV, Sinnock P, Browner WS, Braveman P, Showstack JA. Lower-extremity amputation in people with diabetes. Epidemiology and prevention. Diabetes Care. 1989;12(1):24-31. DOI: https://doi.org/10.2337/diacare.12.1.24

Abbott CA, Garrow AP, Carrington AL, Morris J, Van Ross ER, Boulton AJ, et al. Foot ulcer risk is lower in South-Asian and african-Caribbean compared with European diabetic patients in the U.K.: the North-West diabetes foot care study. Diabetes Care. 2005;28(8):1869-75. DOI: https://doi.org/10.2337/diacare.28.8.1869

Chaturvedi N, Abbott CA, Whalley A, Widdows P, Leggetter SY, Boulton AJ. Risk of diabetes-related amputation in South Asians vs. Europeans in the UK. Diabet Med. 2002;19(2):99-104. DOI: https://doi.org/10.1046/j.1464-5491.2002.00583.x

Dash S, Thakur AK. Perception of vibration threshold is a marker of diabetic neuropathy. Natl J Physiol Pharm Pharmacol. 2017;7(9):1003-6. DOI: https://doi.org/10.5455/njppp.2017.7.0518326052017